| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.22 | 5e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.19 | 3e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.009 |